Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Brodalumab: 5-Year US Pharmacovigilance Report.
Lebwohl MG, Koo JY, Armstrong AW, Strober BE, Martin GM, Rawnsley NN, Goehring EL Jr, Jacobson AA. Lebwohl MG, et al. Among authors: rawnsley nn. Dermatol Ther (Heidelb). 2024 May;14(5):1349-1357. doi: 10.1007/s13555-024-01162-8. Epub 2024 May 9. Dermatol Ther (Heidelb). 2024. PMID: 38724839 Free PMC article.
Brodalumab: 4-Year US Pharmacovigilance Report.
Lebwohl M, Koo J, Leonardi C, Armstrong A, Rawnsley N, Goehring E, Jacobson A. Lebwohl M, et al. Among authors: rawnsley n. J Drugs Dermatol. 2023 Apr 1;22(4):419-422. doi: 10.36849/JDD.7344. J Drugs Dermatol. 2023. PMID: 37026879
Three-year U.S. pharmacovigilance report of brodalumab.
Lebwohl M, Leonardi C, Armstrong A, Rawnsley N, Alexander B, Goehring E Jr, Kerdel F, Jacobson A. Lebwohl M, et al. Among authors: rawnsley n. Dermatol Ther. 2021 Nov;34(6):e15105. doi: 10.1111/dth.15105. Epub 2021 Sep 5. Dermatol Ther. 2021. PMID: 34418244 Free PMC article.
Two-Year US Pharmacovigilance Report on Brodalumab.
Lebwohl M, Leonardi C, Wu JJ, Armstrong A, Rawnsley N, Merchant M, Alexander B, Jacobson A. Lebwohl M, et al. Among authors: rawnsley n. Dermatol Ther (Heidelb). 2021 Feb;11(1):173-180. doi: 10.1007/s13555-020-00472-x. Epub 2020 Dec 18. Dermatol Ther (Heidelb). 2021. PMID: 33337520 Free PMC article.
One-Year Pharmacovigilance Update of Brodalumab.
Lebwohl M, Leonardi C, Wu JJ, Yamauchi P, Rawnsley N, Merchant M, Alexander B, Jacobson A. Lebwohl M, et al. Among authors: rawnsley n. J Drugs Dermatol. 2020 Aug 1;19(8):807-808. doi: 10.36849/JDD.2020.5138. J Drugs Dermatol. 2020. PMID: 32845586 No abstract available.